Academic Journals Database
Disseminating quality controlled scientific knowledge

Physician Awareness and Utilization of Food and Drug Administration (FDA)-Approved Labeling for Pharmacogenomic Testing Information

ADD TO MY LIST
 
Author(s): Eric J. Stanek | Christopher L. Sanders | Felix W. Frueh

Journal: Journal of Personalized Medicine
ISSN 2075-4426

Volume: 3;
Issue: 2;
Start page: 111;
Date: 2013;
Original page

Keywords: pharmacogenomics | physician | drug labeling | survey

ABSTRACT
We surveyed 10,303 United States physicians on where they obtain pharmacogenomic testing information. Thirty-nine percent indicated that they obtained this from drug labeling. Factors positively associated with this response included older age, postgraduate instruction, using other information sources, regulatory approval/ recommendation of testing, reliance on labeling for information, and perception that patients have benefited from testing. Physicians use pharmacogenomic testing information from drug labeling, highlighting the importance of labeling information that is conducive to practice application.

Tango Jona
Tangokurs Rapperswil-Jona

     Save time & money - Smart Internet Solutions